NDC 31722-653 – Atazanavir
Atazanavir Sulfate 150 mg/1 · Capsule · Oral
Product NDC31722-653
Product details
- Brand name
- Atazanavir
- Generic name
- Atazanavir
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA212278
- Marketed since
- February 7, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Protease Inhibitor
Active ingredients
- Atazanavir Sulfate 150 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 31722-653-10 | 1000 CAPSULE in 1 BOTTLE (31722-653-10) | Feb 7, 2022 |
| 31722-653-31 | 100 BLISTER PACK in 1 CARTON (31722-653-31) / 10 CAPSULE in 1 BLISTER PACK | Feb 7, 2022 |
| 31722-653-60 | 60 CAPSULE in 1 BOTTLE (31722-653-60) | Feb 7, 2022 |
Other Atazanavir products
- 31722-654 Atazanavir Sulfate 200 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-655 Atazanavir Sulfate 300 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 42385-920 Atazanavir Sulfate 150 mg/1 · Capsule · Laurus Labs Limited
- 42385-921 Atazanavir Sulfate 200 mg/1 · Capsule · Laurus Labs Limited
- 42385-922 Atazanavir Sulfate 300 mg/1 · Capsule · Laurus Labs Limited